# Prognostic role of 18FDG-PET/CT based biomarker, tumor grading and immunohistochemical markers in breast cancer survival

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41598-026-76747-8) · 2026-11-08 · Life
Page: https://themorning.science/story/prognostic-role-of-18fdg-pet-ct-based-biomarker-tumor-grading-and-immunohistoche-cebc8d71c6801f45
Kind: research · Impact: low

## In brief

- A study examines the prognostic role of 18FDG-PET/CT-based biomarkers in breast cancer survival.
- The study also assesses tumor grading and immunohistochemical markers as survival predictors.
- The article is listed on nature.com with the identifier s41598-026-76747-8; no summary was provided.

## Why it matters

It tests whether imaging-derived biomarkers, alongside standard tumor grading and immunohistochemistry, can help predict breast cancer survival, which matters for researchers developing prognostic tools.

## Coverage

- [Prognostic role of 18FDG-PET/CT based biomarker, tumor grading and immunohistochemical markers in breast cancer survival](https://www.nature.com/articles/s41598-026-76747-8) — Biological sciences : nature.com subject feeds, 2026-11-08

Tags: breast cancer, pet-ct, prognosis, biomarkers, oncology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science